Molecule Ecosystem, December 2024
2024 Recap, Pump Science Updates, Molecule is Hiring, DeSci Mindshare is Growing, X Round-up
Happy New Year!
2024 was an incredible year for DeSci. People are beginning to recognize the impact that DeSci will have on accelerating research. New products, DAOs, published articles, and events all played a role in the soaring attention. This is just the start.
Molecule’s 2024 Recap
This year, we put the power to fund & contribute to innovative research back in the hands of the people. Since then, users have contributed over 600 ETH to fund Catalyst projects.
Pump Science
Molecule brought DeSci to Solana with pump.science to gamify research and accelerate onchain science.
New BioDAOs
It was a big year for BioDAO launches 🌐
PsyDAO launched on Bicycle Day in an homage to Albert Hoffman, creator of LSD, and funded the first DeSci AI Agents project.
Cerebrum DAO launched with tons of big brain energy—attracting investment from Boost VC and minting the first IP-NFT using POI.
We also saw the launch of the second BIO Protocol cohort with Quantum Bio DAO, Curetopia, and Long COVID Labs.
BIO Protocol
BIO took on a new form, launching a new financial layer for DeSci to accelerate the flow of capital and talent into onchain science.
This year, we have seen a boom in IPTs thanks to Catalyst and new IPTs launching out of Molecule ecosystem DAOs 🌐
After Binance Labs invested in BIO Protocol, CZ joined the team during DeSci Day to share his thoughts on the future of onchain science funding.
Pump Science Partners with Pulse
Pulse is a wearables company that enables users to track heart rate and V02 and earn from the data they generate. This partnership will open opportunities to take future Pump Science compounds and do decentralized human studies—streaming data directly from participants.
The Molecule IPT Dashboard is Live
Molecule has launched the IPT Dashboard to easily follow along with all of the IPTs in the Molecule ecosystem. Quickly access token price, market cap, social media links, and onchain data all in one place.
You can find the dashboard on the main site.
What’s on the Pump Science Calendar?
Pump Science is accelerating onchain research with new partnerships and compounds:
VitaDAO Compounds Launching on Pump Science: A few years ago, VitaDAO launched the Longevity Prize with a mission to find new longevity compounds to accelerate research. These compounds will be launching on Pump Science in the coming month.
Open Call for Drug Devs: Pump Science is looking for drug devs to steward the operations and success of the new compounds launching on the platform. These devs will lead the strategy, operations, and marketing for the project. If you are interested, please apply here.
$BIO Airdrop to $URO and $RIF Holders: Eligable $URO and $RIF holders are now able to claim their $BIO airdrop. Check out all the details on this post.
Molecule is Hiring
Are you passionate about accelerating science and democratizing funding for breakthrough research? Join our team!
Molecule is hiring for engineering, ops, and creative roles.
View all open roles at: https://molecule.xyz/careers
DeSci Mindshare is Growing
DeSci has seen an explosion in mindshare across crypto and Web3. Mindshare is generally calculated based on social media engagement, search volume and trends, general narrative growth, and media coverage.
In just 11 months, DeSci had a 2,640% increase—the most across any other category in crypto.
Thanks for Reading!
If you enjoyed this read, subscribe to our newsletter and stay updated as the ecosystem grows. Please reach out to us with any questions or ideas, visit our website, or join our Discord to interact directly with our team. We’re really looking forward to joining forces with our community to create a world where patients directly fund researchers developing the next therapeutic breakthrough they need and building an open, inclusive, and collaborative ecosystem.
Disclaimer: The views and opinions expressed in this newsletter are solely those of the individual authors and contributors. This content is provided for informational purposes only and should not be interpreted as investment advice, endorsement, or recommendation. Readers are advised to conduct their own research and consult with a professional advisor before making any investment decisions.
 | A guest post by
|